Clinical Trials Directory

Trials / Completed

CompletedNCT04694547

Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)

Ketogenic Diet Survey in GSDV

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Nicoline Løkken · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this survey is to report experiences with variants of a ketogenic diet in a group of individuals diagnosed with McArdle disease (glycogen storage disease type V). Further more the survey will report on physical activity, fatigue, sleep and quality of life in this cohort.

Detailed description

Currently, there is no satisfactory treatment for McArdle disease. The limitation in people with McArdle disease is due to a limited availability of energy in the muscle due to affected carbohydrate metabolism. A key element in improving muscle function is therefore to introduce alternative energy sources. Ketone bodies are a well-known source of energy for both brain and muscle. Ketone bodies are produced during fasting or when following a ketogenic diet. A ketogenic diet is a diet high in fat and low in carbohydrates. The classic ketogenic diet contains up to 90% fat, but there are several alternative diets with less fat, including a modified ketogenic diet, Atkins diet, LCHF (low carb high fat), OMAD (one meal a day) and more. This survey will collect information on all variations. The rationale for a ketogenic diet for persons with McArdle disease makes good sense in theory, as the diet would contribute with a new source of energy (ketone bodies) independent of the affected carbohydrate breakdown. However, evidence is sparse on whether the diet actually works. The primary purpose of this survey is to report experiences with variants of the ketogenic diet in a group of individuals diagnosed with McArdle disease. Secondarily this survey will collect information on physical activity, fatigue, sleep and quality of life in this cohort

Conditions

Interventions

TypeNameDescription
OTHERThere is no intervention, as this is a survey studySurvey

Timeline

Start date
2021-01-10
Primary completion
2022-11-01
Completion
2022-12-01
First posted
2021-01-05
Last updated
2023-02-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04694547. Inclusion in this directory is not an endorsement.